GlassScriptPhysician profile
Leanna M Mosher
NPI 1407050081
$1,137.40
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $359 · 2021: $489 · 2022: $87.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $483.13 | 2019-2022 | |
| Pfizer INC. | $111.35 | 2020-2022 | |
| Daiichi Sankyo INC. | $83.56 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.11 | 2019-2021 | |
| Allergan, INC. | $55.82 | 2019-2020 | |
| Evofem Biosciences, INC. | $46.27 | 2021 | |
| Therapeuticsmd, INC. | $45.48 | 2020-2021 | |
| Avion Pharmaceuticals | $39.97 | 2019-2020 | |
| Scynexis, INC. | $31.10 | 2022 | |
| Currax Pharmaceuticals LLC | $27.48 | 2020-2021 | |
| Amgen INC. | $26.64 | 2021 | |
| Mylan Pharmaceuticals INC. | $24.00 | 2021 | |
| Mayne Pharma Commercial LLC | $21.58 | 2021 | |
| Hologic Sales and Service, LLC | $18.52 | 2021 | |
| Bausch Health US, LLC | $16.09 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.37 | 2022 | |
| Exeltis, USA INC. | $13.93 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanna Mosher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.